| Dr Eric F Schulte, MD | |
|
7863 Broadway, Suite 140, Merrillville, IN 46410-5553 | |
| (219) 769-3678 | |
| (219) 736-5638 |
| Full Name | Dr Eric F Schulte |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 43 Years |
| Location | 7863 Broadway, Merrillville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194724377 | NPI | - | NPPES |
| 200911270A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 01035204A (Indiana) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01035204A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Community Hospital | Munster, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
News Archive
Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, has announced that the results of its open-label Exhale Drug-Eluting Stent feasibility study have been published in the October issue of the Journal of Thoracic and Cardiovascular Surgery.
Osteoporosis drugs have significantly reduced the risk of bone fractures for millions of people, but also have been linked to unusual fractures of the femur (thigh bone).
The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," in their application to the development of the virus triage detection system for the H1N1 virus.
› Verified 1 days ago
| Entity Name | Cardiodiagnostics, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144279241 PECOS PAC ID: 6406755503 Enrollment ID: O20040107000901 |
News Archive
Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, has announced that the results of its open-label Exhale Drug-Eluting Stent feasibility study have been published in the October issue of the Journal of Thoracic and Cardiovascular Surgery.
Osteoporosis drugs have significantly reduced the risk of bone fractures for millions of people, but also have been linked to unusual fractures of the femur (thigh bone).
The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," in their application to the development of the virus triage detection system for the H1N1 virus.
› Verified 1 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, has announced that the results of its open-label Exhale Drug-Eluting Stent feasibility study have been published in the October issue of the Journal of Thoracic and Cardiovascular Surgery.
Osteoporosis drugs have significantly reduced the risk of bone fractures for millions of people, but also have been linked to unusual fractures of the femur (thigh bone).
The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," in their application to the development of the virus triage detection system for the H1N1 virus.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric F Schulte, MD 7863 Broadway, Suite 140, Merrillville, IN 46410-5553 Ph: (219) 769-3678 | Dr Eric F Schulte, MD 7863 Broadway, Suite 140, Merrillville, IN 46410-5553 Ph: (219) 769-3678 |
News Archive
Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, has announced that the results of its open-label Exhale Drug-Eluting Stent feasibility study have been published in the October issue of the Journal of Thoracic and Cardiovascular Surgery.
Osteoporosis drugs have significantly reduced the risk of bone fractures for millions of people, but also have been linked to unusual fractures of the femur (thigh bone).
The U.S. Food and Drug Administration (FDA) has issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia.
VeriChip Corporation ("VeriChip") (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," in their application to the development of the virus triage detection system for the H1N1 virus.
› Verified 1 days ago
Dr. Mihas Mamu Kodenchery, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5800 Broadway, Suite A-j, Merrillville, IN 46410 Phone: 219-884-9185 | |
Omar Al Dhaybi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 90 W 86th Ave, Merrillville, IN 46410 Phone: 219-791-1555 | |
Virginia Tan Tabib, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8127 Merrillville Rd, Merrillville, IN 46410 Phone: 219-769-4855 Fax: 219-757-5629 | |
Dr. Mohammed Asgar, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 5490 Broadway Ste 106, Merrillville, IN 46410 Phone: 219-939-7130 Fax: 219-951-0883 | |
Gaurav Agarwal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6061 Broadway, Merrillville, IN 46410 Phone: 219-884-2640 Fax: 219-884-2810 | |
Larry R Brazley, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 255 E 90th Dr, W1, Merrillville, IN 46410 Phone: 219-791-0248 Fax: 219-791-0251 | |
Stephanie D Marshall, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8684 Connecticut St Ste A, Merrillville, IN 46410 Phone: 192-472-8990 Fax: 219-472-0270 |